Mangalam Drugs And Organics profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | ||||
|---|---|---|---|---|---|
| −35.2% | −35.2% | 4.7% | −6.3% | ||
| −13.0% | −13.0% | 1.9% | −2.6% | ||
| −22.6% | −22.6% | 11.2% | 1.6% | ||
| −11.7% | −14.6% | 8.4% | 1.0% | ||
Margins | |||||
| −3.9% | −6.4% | 11.3% | 4.7% | ||
| −14.3% | −14.3% | 6.0% | 0.7% | ||
| — | 60.8% | −32.7% | — | ||
| −18.2% | −20.9% | 1.5% | −3.0% | ||
| −16.5% | −19.1% | 2.1% | −2.5% | ||
| — | −19.1% | 2.1% | −2.5% | ||
| −3.3% | −3.3% | 7.0% | −3.0% | ||
Additional | |||||
| 9.6% | 8.6% | −40.4% | 18.1% | ||
| −35.2% | −35.2% | 4.7% | −6.3% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.